| __timestamp | Pfizer Inc. | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 40028000000 | 116287000 |
| Thursday, January 1, 2015 | 39203000000 | 136004000 |
| Friday, January 1, 2016 | 40495000000 | 203017000 |
| Sunday, January 1, 2017 | 41306000000 | 287023000 |
| Monday, January 1, 2018 | 42399000000 | 393541000 |
| Tuesday, January 1, 2019 | 41531000000 | 376095000 |
| Wednesday, January 1, 2020 | 33216000000 | 467938000 |
| Friday, January 1, 2021 | 50467000000 | 504714000 |
| Saturday, January 1, 2022 | 65986000000 | 580017000 |
| Sunday, January 1, 2023 | 28809000000 | 523742000 |
| Monday, January 1, 2024 | 45776000000 |
Unveiling the hidden dimensions of data
In the ever-evolving pharmaceutical landscape, Pfizer Inc. and Supernus Pharmaceuticals, Inc. have showcased contrasting trajectories in their gross profit margins over the past decade. From 2014 to 2023, Pfizer's gross profit saw a significant fluctuation, peaking in 2022 with a remarkable 56% increase from its 2014 figures. However, 2023 marked a downturn, with profits dropping by over 56% from the previous year. In contrast, Supernus Pharmaceuticals, though smaller in scale, demonstrated a steady upward trend, with a 350% increase in gross profit from 2014 to 2023. This growth highlights Supernus's strategic positioning in niche markets, while Pfizer's volatility underscores the challenges faced by larger entities in maintaining consistent growth. As the pharmaceutical industry continues to adapt to global health challenges, these insights provide a glimpse into the financial dynamics shaping the future of healthcare.
Who Generates Higher Gross Profit? Pfizer Inc. or Alnylam Pharmaceuticals, Inc.
Pfizer Inc. vs Pharming Group N.V.: A Gross Profit Performance Breakdown
Pfizer Inc. and Ligand Pharmaceuticals Incorporated: A Detailed Gross Profit Analysis
Gross Profit Analysis: Comparing Pfizer Inc. and Taro Pharmaceutical Industries Ltd.
Who Generates Higher Gross Profit? Alnylam Pharmaceuticals, Inc. or Supernus Pharmaceuticals, Inc.
Gross Profit Trends Compared: Catalent, Inc. vs Supernus Pharmaceuticals, Inc.
Ascendis Pharma A/S vs Supernus Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Trends Compared: Pharming Group N.V. vs Supernus Pharmaceuticals, Inc.
Gross Profit Comparison: Amneal Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc. Trends
HUTCHMED (China) Limited and Supernus Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Gross Profit Comparison: Ligand Pharmaceuticals Incorporated and Supernus Pharmaceuticals, Inc. Trends
Who Generates Higher Gross Profit? Supernus Pharmaceuticals, Inc. or BioCryst Pharmaceuticals, Inc.